Genotype-dependent miR-499/SOX5 axis regulation and its association with chronic low back pain risk and severity

This case-control study genotyped 180 chronic low back pain (CLBP) patients and 180 healthy controls for the miR-499 rs3746444 polymorphism and measured miR-499 and SOX5 expression in blood. The C allele and mutant genotypes (TC/CC) were associated with increased CLBP risk (CC genotype OR=3.457, P=0.002), and miR-499 was upregulated while SOX5 was downregulated specifically in CLBP patients carrying the C allele, with miR-499 levels correlating with pain (VAS) and disability (ODI) scores. Lab experiments (RIP, luciferase assay) confirmed SOX5 as a direct target of miR-499, but the authors are explicit that this is correlational genetic/molecular association work, not proof that this pathway causes pain.

AI summary · from the full text · reviewed by Pukhraj Gaheer, Medical Student, Queen's University before publishing

Why it mattersThis is basic-science/genetic biomarker research relevant to understanding CLBP susceptibility, not a treatment study, so it has limited immediate bearing on surgical decision-making but may inform future biomarker or precision-medicine research.

Presenting this at rounds? Start here

• ?If a patient's CC genotype at rs3746444 were known, would that change how aggressively you pursue psychosocial or mechanical risk factor modification, given the authors' own caution that genetics is just one piece of a biopsychosocial picture?
• ?Given that miR-499 levels correlated with VAS and ODI but were measured in peripheral blood rather than disc tissue, would you trust this as a future disease-activity biomarker before local tissue studies validate it?